Skip to main content
Top
Published in: Journal of Mammary Gland Biology and Neoplasia 1-2/2016

01-06-2016 | Erratum

Erratum to: A Comparative Study on the In Vitro Effects of the DNA Methyltransferase Inhibitor 5-Azacytidine (5-AzaC) in Breast/Mammary Cancer of Different Mammalian Species

Authors: Rebecca M. Harman, Theresa M. Curtis, David J. Argyle, Scott A. Coonrod, Gerlinde R. Van de Walle

Published in: Journal of Mammary Gland Biology and Neoplasia | Issue 1-2/2016

Login to get access

Excerpt

Erratum to: J Mammary Gland Biol Neoplasia
Metadata
Title
Erratum to: A Comparative Study on the In Vitro Effects of the DNA Methyltransferase Inhibitor 5-Azacytidine (5-AzaC) in Breast/Mammary Cancer of Different Mammalian Species
Authors
Rebecca M. Harman
Theresa M. Curtis
David J. Argyle
Scott A. Coonrod
Gerlinde R. Van de Walle
Publication date
01-06-2016
Publisher
Springer US
Published in
Journal of Mammary Gland Biology and Neoplasia / Issue 1-2/2016
Print ISSN: 1083-3021
Electronic ISSN: 1573-7039
DOI
https://doi.org/10.1007/s10911-016-9353-8

Other articles of this Issue 1-2/2016

Journal of Mammary Gland Biology and Neoplasia 1-2/2016 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine